Expert Video - What are hypomethylating agents and when are they used for MDS?

MDS experts, Dr Alan List and Dr David Sallman, provide an overview of hypomethylating agents for the treatment of myelodysplastic syndromes (MDS). These medications work by turning on genes to kill the cancer cells. Examples discussed are azacitidine and decitabine. The doctors describe how these drugs are given, how they work, and potential side effects.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.


This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by an educational grant from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis Pharmaceuticals, and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.